ev in cisplatin-ineligible patients with locally advanced or metastatic urothelial cancer
Published 3 years ago • 48 plays • Length 5:23Download video MP4
Download video MP3
Similar videos
-
3:56
potential for enfortumab vedotin plus pembrolizumab in cisplatin-ineligible locally advanced or ...
-
2:43
ev-103: ev with pembrolizumab in cisplatin-ineligible urothelial carcinoma
-
0:57
pros in advanced cisplatin-ineligible uc: first-line ev ± pembrolizumab
-
2:58
ev-201: enfortumab vedotin for cisplatin-ineligible bladder cancer
-
4:15
ev-201: enfortumab an option for cisplatin-ineligible advanced uc | arjun balar
-
6:02
ev-103: ev pembrolizumab as a promising first-line option for urothelial carcinoma
-
6:01
ev-201, ev-301 and unite: enfortumab vedotin in advanced urothelial cancer
-
3:45
treatment options for cisplatin-ineligible patients with advanced bladder cancer
-
8:07
long term outcome of enfortumab vedotin pembrolizumab in first line locally advanced or metast...
-
2:09
ev-103: neoadjuvant enfortumab vedotin in cis-ineligible mibc
-
1:23
how effective is pembrolizumab in cisplatin-ineligible bladder cancer? results from keynote-052
-
0:35
ev-302: 1l enfortumab vedotin in combination with pembrolizumab
-
6:09
erdafitinib (erda) or erda plus cetrelimab for patients with metastatic or locally advanced urot...
-
2:55
ev-103: enfortumab vedotin plus pembrolizumab for locally advanced or metastatic urothelial carc...
-
13:47
ev-103: enfortumab vedotin and pembrolizumab in urothelial carcinoma
-
2:20
ev-201: enfortumab vedotin for bladder cancer
-
4:45
pre0807: neoadjuvant nivolumab/lirilumab in cisplatin ineligible patients with mibc
-
13:25
treatment considerations for patients with cisplatin-ineligible bladder cancer
-
1:27
dr. sonpavde on enfortumab vedotin data in bladder cancer